DNA as Intellectual Property: Can Your Genes Be Owned?

Introduction The United States Supreme Court ruled unanimously in June 2013 in the case of Association for Molecular Pathology v. Myriad Genetics, Inc. that naturally occurring DNA sequences cannot be patented. This judgement was celebrated as a triumph for patients, scientists, and healthcare professionals who had been unable to afford BRCA genetic testing because a […]

Deltagen Inc Patent Portfolio – Exemplary Landscape Overview

Deltagen Inc is a leading technology company focused on innovation and creating and monetizing its Intellectual Property across jurisdictions. This exemplary study/report presents a high-level brief analysis of the Patent Portfolio of the Corporate, and various attributes/parameters on which the said entities Patent Portfolio is being represented. Deltagen Inc along with its key subsidiaries has […]

Biotechnology Patent Landscape in India: Analyzing Emerging Legal Issues and Challenges

INTRODUCTION Biotechnology Patent means the legal power given to the innovators to prevent third parties from producing, using or importing biotechnological inventions. A biotechnology patent, as described by Moore et al. (2019), comprises inventions pertaining to genetic material, living things, and procedures involving the manipulation of biological components.[1] It encompasses a wide range of technologies […]